Holen Sie sich die Stockscreener-App
6.73
2.54%
0.20
Prothena Corporation Plc Aktie (PRTA) Neueste Nachrichten
What analysts say about Prothena Corporation plc stockExplosive trading opportunities - Autocar Professional
Prothena Corporation plc (NASDAQ:PRTA) Receives $31.50 Average Price Target from Analysts - Defense World
Prothena Corporation plc Stock Analysis and ForecastFree Stock Market Forecast Reports - jammulinksnews.com
Is Prothena Corporation plc a good long term investmentExceptional gains - jammulinksnews.com
What drives Prothena Corporation plc stock priceRecord-breaking gains - jammulinksnews.com
How to Take Advantage of moves in (PRTA) - news.stocktradersdaily.com
Why Prothena Corporation plc stock attracts strong analyst attentionFree Smart Investment Opportunities - Newser
What makes Prothena Corporation plc stock price move sharplyFree Stock Market Practical Discussion Forums - Newser
How Prothena Corporation plc stock performs during market volatilityFree Capital Allocation Plans - Newser
Cambridge Investment Research Advisors Inc. Acquires Shares of 10,164 Prothena Corporation plc (NASDAQ:PRTA) - Defense World
Piper Sandler Reduces Prothena (PRTA) Price Target to $81 from $110 Following AFFIRM-AL Trial Discontinuation - MSN
PRTA Dives 53.5% YTD: Will the Restructuring Effort Boost Prospects? - sharewise.com
Roche’s Phase 3 Move Boosts Outlook for Prothena Corporation plc (PRTA) - MSN
Prothena to lay off majority of staff; Zealand shares obesity drug data - BioPharma Dive
Peninsula biotech will cut half its workforce, but partner takes Parkinson's drug into late-stage trial - The Business Journals
Prothena announces 63% workforce reduction following birtamimab halt - Investing.com
Prothena (PRTA) Cuts Workforce by 63% to Reduce Costs - GuruFocus
Prothena (PRTA) Shares Rise Following Corporate Restructuring an - GuruFocus
Prothena Announces Major Workforce Reduction to Cut Costs - TipRanks
Prothena (PRTA) Adjusts 2025 Financial Outlook Amid Reorganizati - GuruFocus
Prothena Announces Corporate Restructuring | PRTA Stock News - GuruFocus
Prothena (PRTA) Announces Leadership Changes Amid Workforce Reduction | PRTA Stock News - GuruFocus
Prothena to cut workforce by 63% amid strategic review - Investing.com
Prothena announces corporate restructuring - MarketScreener
Prothena Announces Corporate Restructuring - Business Wire
Chardan Lowers Prothena (PRTA) Price Target Following AFFIRM-AL Trial Failure - MSN
Prothena (NASDAQ:PRTA) Shares Pass Below 200 Day Moving Average – Time to Sell? - Defense World
Roche And Prothena: Why Moving On Makes Sense (OTCMKTS:RHHBY) - Seeking Alpha
(PRTA) Trading Signals - news.stocktradersdaily.com
Financial Analysis: Prothena Corporation plc (PRTA)’s Ratios Unveil Key Insights - DWinneX
Prothena stock rises on Parkinson's trial update (PRTA:NASDAQ) - Seeking Alpha
Prothena’s Prasinezumab Advances to Phase III for Parkinson’s - TipRanks
Prothena partner Roche advances Parkinson’s drug to phase 3 By Investing.com - Investing.com Nigeria
Prothena’s Partner Roche to Advance Prasinezumab into Phase III Development for Early-Stage Parkinson's Disease - BioSpace
Prothena's Partner to Advance Potential Parkinson's Treatment to Phase 3 Development - marketscreener.com
Prothena's Partner Roche to Advance Prasinezumab into Phase III - GuruFocus
Prothena’s SWOT analysis: stock faces challenges after trial setback - Investing.com
Prothena’s SWOT analysis: stock faces challenges after trial setback By Investing.com - Investing.com South Africa
4.56%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):